ARQT - Arcutis Biotherapeutics Inc
24.59
-0.230 -0.935%
Share volume: 973,183
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$24.82
-0.23
-0.01%
Summary score
48%
Profitability
43%
Dept financing
32%
Liquidity
75%
Performance
51%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-74.76%
Return on assets
-11.27%
Return on sales
-1667.32%
Return on invested capital
185.49%
Total debt ratio
57.59%
Debt ratio change over timeo
-0.8%
Current Ratio
7.6%
Quick Ratio
6.88%
Cash Position Ratio
2.01%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-0.24%
Return on sales
-4.82%
Return on invested capital
0%
Total debt ratio
57.39%
Debt ratio change over timeo
0%
Current Ratio
3.41%
Quick Ratio
3.21%
Cash Position Ratio
0.46%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.76%
Return on sales
14.2%
Return on invested capital
0%
Total debt ratio
56.24%
Debt ratio change over time
0%
Current Ratio
3.17%
Quick Ratio
2.99%
Cash Position Ratio
0.33%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-104.92%
Return on sales
-134.39%
Return on invested capital
0%
Total debt ratio
-79.78%
Debt ratio change over time
-0.8%
Current Ratio
3.8%
Quick Ratio
4.18%
Cash Position Ratio
0.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARQT | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -74.76% | 12.23% | 10.41% | 0% |
| Return on assets | -11.27% | 4.74% | 3.19% | 1.73% |
| Return on sales | -1667.32% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 185.49% | 8.04% | 10.95% | 0% |
| Profitability | 25% | 76% | 60% | 29% |
| Total debt ratio | 57.59% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -0.8% | -20.57% | -85.61% | 17.33% |
| Dept financing | 15% | 21% | 16% | 50% |
| Current Ratio | 3.41% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.21% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.46% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 9% | 13% | 8% |
| Short-term ratios | ARQT | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -0.24% | 6.06% | 4.18% | 1.7% |
| Return on sales | -4.82% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 57.39% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 20% | 15% | 25% |
| Current Ratio | 3.41% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.21% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.46% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 28% | 38% | 18% |